Event Details
- Teleconference scheduled for 30th July 2026 at 05:30 PM
- Purpose: Discussion of financial performance for quarter ended 30th June 2026 (Q1 FY2027)
- Participants: Investors and analysts
Conference Call Access Information
Universal Dial-in Numbers:
- +91 22 6280 1439
- +91 22 7115 8803
Toll-Free Numbers:
India National Toll Free: 1 800 120 1221
International Toll Free Numbers:
- Argentina: 0080014243444
- Australia: 0080014243444
- Belgium: 0080014243444
- Canada: 01180014243444
- China: 4008428405
- France: 0800914745
- Germany: 0080014243444
- Hong Kong: 800964448
- Italy: 0080014243444
- Japan: 00531161110
- Netherlands: 08000229808
- Poland: 008001124248
- Singapore: 8001012045
- South Korea: 00180014243444
- Sweden: 0080014243444
- Thailand: 00180014243444
- UK: 08081011573
- USA: 18667462133
Registration
- Diamond Pass registration link provided: https://services.choruscall.in/DiamondPassRegistration/register?confirmationNumber=4636017&linkSecurityString=277f6647f0
Company Representative
- Signed by CHINTAN M. TRIVEDI, Company Secretary
- Digital signature timestamp: 2026.07.17 18:53:11 +05'30'
- Contact email: investorservices@torrentpharma.com
Financial Impact
- Financial impact not quantified in the disclosure - announcement only for scheduled conference call
- No financial figures, performance metrics, or operational updates provided in this filing